The leronlimab/vyrologix stars are good -P2 CD1
Post# of 153778
(Total Views: 564)
Posted On: 02/09/2021 9:55:34 AM
The leronlimab/vyrologix stars are good
-P2 CD10 Covid19 safer than standard of care
-hundreds of HIV patients prove it is safe over years
-P3 CD12 Covid19 reviews- continue on without changes
-open label extension
-Medicare billing code
-P3 CD12 Covid19 approximately 87 out of 390 didn't make it overall (both arms) which means the entire trial mortality (22%) is better than standard of care in zyesami (30%). When we hear of CD12 details, the Leronlimab treatment arm will IMO show less than a 20% mortality rate and will be a big improvement over the standard of care mortality rate.
To me it looks like Leronlimab will soon be a very nice tool to have.
IMHO
-P2 CD10 Covid19 safer than standard of care
-hundreds of HIV patients prove it is safe over years
-P3 CD12 Covid19 reviews- continue on without changes
-open label extension
-Medicare billing code
-P3 CD12 Covid19 approximately 87 out of 390 didn't make it overall (both arms) which means the entire trial mortality (22%) is better than standard of care in zyesami (30%). When we hear of CD12 details, the Leronlimab treatment arm will IMO show less than a 20% mortality rate and will be a big improvement over the standard of care mortality rate.
To me it looks like Leronlimab will soon be a very nice tool to have.
IMHO
(12)
(0)CytoDyn Inc (CYDY) Stock Research Links
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.